Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
The latest update is out from 4DMedical Ltd ( (AU:4DX) ).
4DMedical Ltd has announced the issuance of unquoted equity securities, including performance rights, options with varied expiration dates and prices, and new class options. These securities are part of an employee incentive scheme aimed at strengthening its workforce and driving long-term growth, emphasizing the company’s commitment to innovation and investments in its strategic workforce planning.
The most recent analyst rating on (AU:4DX) stock is a Buy with a A$2.50 price target. To see the full list of analyst forecasts on 4DMedical Ltd stock, see the AU:4DX Stock Forecast page.
More about 4DMedical Ltd
4DMedical Ltd operates within the healthcare and medical technology industry, offering innovative imaging and diagnostic solutions specializing in respiratory health.
Average Trading Volume: 5,143,817
Technical Sentiment Signal: Buy
Current Market Cap: A$1.55B
For an in-depth examination of 4DX stock, go to TipRanks’ Overview page.